Skip to main content
SpringerLink
Log in

Cholestasis and hepatic drug metabolism

Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The antipyrine metabolic clearance rate (MCR) was studied in two groups of patients with similar degrees of cholestasis and hepatic damage, but differing mechanisms of cholestasis. The plasma disappearance rate of antipyrine in 18 patients with extrahepatic cholestasis and 11 patients with intrahepatic cholestasis was compared with that of two groups of control subjects without liver disease who were matched for age. Whereas no significant difference was observed for the antipyrine MCR between patients with extrahepatic cholestasis and their controls [30.7±11.2 (sd) as against 31.6±10.0 ml/min], the antipyrine MCR was significantly lower (P<0.001) in the patients with intrahepatic cholestasis than in their controls (16.2±4.5 vs 37.4±17.3 ml/min). These results suggest that cholestasisper se does not change the rate of metabolism of drugs by the liver. The decrease of antipyrine MCR in patients with intrahepatic cholestasis could be due to a reduced functional parenchymal mass related to some degree of hepatic necrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andreasen PB, Ranek L, Statland BE, Tygstrup N: Clearance of antipyrine-dependence of quantitative liver function. Eur J Clin Invest 4:129–134, 1976

    Google Scholar 

  2. Branch RA, Herbert CM, Read AE: Determinants of serum antipyrine half-lives in patients with liver disease. Gut 14:569–573, 1973

    Google Scholar 

  3. Hepner GW, Vesell ES, Lipton A, Harvey HA, Wilkinson GR, Schenker S: Disposition of aminopyrine, antipyrine, diazepam and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: Diazepam breath test and correlation in drug elimination. J Lab Clin Med 90:440–446, 1977

    Google Scholar 

  4. Miguet JP, Allemand H, Joanne C, Dhumeaux D: La clairance de l'antipyrine un test pour apprécier la fonction hépatique d'oxydation des médicaments. Etude au cours de la cirrhose. Nouv Presse Med 7:4209–4211, 1978

    Google Scholar 

  5. Carulli N, Manenti F, Ponz de Leon M, Ferrari A, Salvioli G, Gallo M: Alteration of drug metabolism during cholestasis in man. Eur J Clin Invest 5:455–462, 1975

    Google Scholar 

  6. Elfström J, Lindgren S: Disappearance of phenazone from plasma in patients with obstructive jaundice. Eur J Clin Pharmacol 7:467–471, 1974

    Google Scholar 

  7. Andreasen PB, Greisen G: Phenazone metabolism in patients with liver disease. Eur J Clin Invest 6:21–26, 1976

    Google Scholar 

  8. Galizzi J, Long RG, Billing BH, Sherlock S: Assessment of the [14C]aminopyrine breath-test in liver disease. Gut 19:40–45, 1978

    Google Scholar 

  9. Breimer DD, Zilly W, Richter E: Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recovery. Clin Pharmacol Ther 18:433–440, 1975

    Google Scholar 

  10. Burnett DA, Barak AJ, Tuma DJ, Sorrel MF: Altered elimination of antipyrine in patients with acute viral hepatitis. Gut 17:341–344, 1976

    Google Scholar 

  11. McHorse TS, Wilkinson GR, Johnson RF, Schenker S: Effect of acute viral hepatitis in man on the disposition and elimination of meperidine. Gastroenterology 68:775–780, 1975

    Google Scholar 

  12. Williams RL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M: Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: Lidocaine and indocyanine green. Clin Pharmacol Ther 20:290–299, 1976

    Google Scholar 

  13. Crooks J, O'Malley K, Stenvenson IH: Pharmacokinetics in the elderly. Clin Pharmacokinet 1:280–296, 1976

    Google Scholar 

  14. Conney AH: Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19:317–366, 1967

    Google Scholar 

  15. Levi AJ, Sherlock S, Wacker D: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1:1275–1279, 1968

    Google Scholar 

  16. Prescott LF, Adjepon-Yamoah KK, Roberts E: Rapid gasliquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol 25:205–207, 1973

    Google Scholar 

  17. Siegel S: Nonparametric Statistics for the Behavioral Sciences. New York, McGraw-Hill Book, 1956

    Google Scholar 

  18. Vesell ES, Lee CJ, Passananti GT, Shively CA: Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs. Pharmacology 10:317–328, 1973

    Google Scholar 

  19. Vuitton D, Miguet JP, Camelot G, Delafin C, Joanne C, Bechtel P, Gillet M, Carayon P: Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in man without liver disease. Gastroenterology 80:112–118, 1981

    Google Scholar 

  20. Miguet JP, Vuitton D, Thebault-Lucas A, Joanne C, Dhumeaux D: Spironolactone and enzyme induction in patients with alcoholic cirrhosis. Gastroenterology 78:996–1000, 1980

    Google Scholar 

  21. Soberman R, Brodie BB, Levy BB, Axelrod J, Hollander V, Steele JM: The use of antipyrine in the measurement of total body water in man. J Biol Chem 179:31–42, 1949

    Google Scholar 

  22. Brodie BB, Axelrod J: The fate of antipyrine in man. J Pharmacol Exp Ther 98:97–104, 1950

    Google Scholar 

  23. Vesell ES, Passananti GT, Glenwright PA, Dvorchik BH: Studies on the disposition of antipyrine, aminopyrine and phenacetin using plasma, saliva, and urine. Clin Pharmacol Ther 18:259–272, 1975

    Google Scholar 

  24. Welch RM, Deangelis RL, Wingfield M, Farmer TW: Elimination of antipyrine from saliva as a measure of metabolism in man. Clin Pharmacol Ther 18:249–258, 1975

    Google Scholar 

  25. Huffman DH, Shoeman DW, Azarnoff DL: Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxyantipyrine in the urine of man. Biochem Pharmacol 23:197–201, 1974

    Google Scholar 

  26. Shand DG: Drug disposition in liver disease. N Engl J Med 296:1527–1528, 1977

    Google Scholar 

  27. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR: The effect of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55:347–359, 1975

    Google Scholar 

  28. Doshi J, Luisada-Opper A, Leevy CM: Microsomal pentobarbital hydroxylase activity in acute viral hepatitis. Proc Soc Exp Biol Med 140:492–495, 1972

    Google Scholar 

  29. Schoene B, Fleischmann RA, Remmer H, Von Oldershausen HF: Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur J Clin Pharmacol 4:65–73, 1972

    Google Scholar 

  30. Denk H, Eckerstorfer R, Rohr HP: The endoplasmic reticulum of the rat liver cell in experimental mechanical cholestasis. Correlated biochemical and ultrastructural-morphometric studies on structure and enzymes composition. Exp Mol Pathol 26:193–203, 1977

    Google Scholar 

  31. Pirttiaho H: Liver size in evaluating drug metabolizing capacity in man. Clin Pharmacol Biopharmacol 17:271–276, 1979

    Google Scholar 

  32. Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of [14C]aminopyrine. Ann Intern Med 83:632–638, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'Hépatologie et Gastroentérologie, Service de Pharmacologie Clinique, Centre Hospitalier Universitaire, 25030, Besancon, France

    J. -P. Miguet MD, Dominique Vuitton MD, J. -P. Deschamps MD, H. Allemand MD, Christiane Joanne, P. Bechtel MD & P. Carayon MD

Authors
  1. J. -P. Miguet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dominique Vuitton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. -P. Deschamps MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Allemand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christiane Joanne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Bechtel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Carayon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miguet, J.P., Vuitton, D., Deschamps, J.P. et al. Cholestasis and hepatic drug metabolism. Digest Dis Sci 26, 718–722 (1981). https://doi.org/10.1007/BF01316861

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01316861

Keywords

Search

Navigation